Declared bankruptcy in Mar 2023
CORZ - Core Scientific, Inc.
NASDAQ
->
Technology
->
Software—Infrastructure
Austin,
United States
Type: Equity
CORZ price evolution
CORZ
| (in millions $) | 29 Oct 2022 | 29 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $3.07 | $3.52 | $0.51 | $1.68 |
| Inventory | ||||
| Total current assets | $213.57 | $511.56 | $808.25 | $756.56 |
| Long term investments | ||||
| Property, plant & equipment | $1177.3 | $1049.07 | $820.18 | $597.3 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $1404 | $1845.16 | $2704.05 | $2438.86 |
| Current liabilities | ||||
| Accounts payable | $43.61 | $31.25 | $15.62 | $11.62 |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $1289.01 | $516.55 | $414.69 | $320.29 |
| Long term debt | $901.02 | $1108.99 | $714.36 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1330.97 | $1428.71 | $1577.34 | $1053.18 |
| Shareholders' equity | ||||
| Retained earnings | -$1666.29 | -$1279.33 | -$477.44 | -$38.4 |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Current assets | ||||
| Cash | ||||
| Short term investments | ||||
| Net receivables | $1.68 | $1.11 | $0.18 | |
| Inventory | ||||
| Total current assets | $756.56 | $70.92 | $11.05 | |
| Long term investments | ||||
| Property, plant & equipment | $597.3 | $85.24 | $81.3 | |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $2438.86 | $225.58 | $162.01 | |
| Current liabilities | ||||
| Accounts payable | $11.62 | $3.06 | $7.5 | |
| Deferred revenue | ||||
| Short long term debt | ||||
| Total current liabilities | $320.29 | $69.65 | $19.47 | |
| Long term debt | $714.36 | $22.13 | $5.28 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $1053.18 | $91.88 | $26.16 | |
| Shareholders' equity | ||||
| Retained earnings | -$38.4 | -$74.74 | -$62.54 | |
| Other shareholder equity | ||||
| Total shareholder equity | ||||
| (in millions $) | 29 Oct 2022 | 29 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $162.57 | $163.97 | $192.52 | $301.8 |
| Cost of revenue | ||||
| Gross Profit | -$27.08 | $12.72 | $70 | $141.37 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $49.58 | $115.88 | $44.9 | $18.93 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $10.64 | -$48.65 | $42.41 | $16.46 |
| Interest expense | -$25.42 | -$4.93 | -$11.4 | -$17.8 |
| Net income | ||||
| Net income | -$434.79 | -$810.48 | -$466.2 | $60.51 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $544.48 | $60.32 | $59.52 | |
| Cost of revenue | ||||
| Gross Profit | $238.86 | $9.39 | $10.53 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $72.34 | $21.6 | $23.02 | |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | $15.76 | |||
| Interest expense | -$44.35 | -$4.44 | -$0.23 | |
| Net income | ||||
| Net income | $47.31 | -$12.21 | -$11.92 | |
| Income (for common shares) | ||||
| (in millions $) | 29 Oct 2022 | 29 Jul 2022 | 30 Apr 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$451.3 | -$445.64 | -$269.1 | -$423.84 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $268.07 | $313.17 | $251.47 | $603.53 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$94.03 | $8.8 | -$21.25 | $122.96 |
| (in millions $) | 31 Jan 2022 | 31 Jan 2021 | 31 Jan 2020 | |
|---|---|---|---|---|
| Net income | ||||
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | -$423.84 | -$15.14 | -$37.36 | |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | $603.53 | $40.72 | $28.69 | |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $122.96 | $1.81 | -$9.5 | |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 364.71M |
| Revenue | $820.86M |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$1.65B |
| Revenue Q/Q | -33.01% |
| Revenue Y/Y | N/A |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | -$4.53 |
|---|---|
| ROA | -78.69% |
| ROE | N/A |
| Debt/Equity | N/A |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 0.17 |
| Quick ratio | N/A |